IP Library Granted Patent US 10,675,290
Granted Patent B2
US 10,675,290 · App. 14/780,265 · Granted Jun 9, 2020

Compositions for use in stimulating bone growth

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,675,290
App. No.
14/780,265
Granted
Jun 9, 2020
Kind
B2
Abstract

The present invention relates to use of a composition for maintenance of bone and/or cartilage health or prevention, alleviation and/or treatment of bone and/or cartilage disorders.

Claims (19)

1. A method for potentiating the effects of oleuropein on bone formation and/or cartilage anabolism, the method comprising administering a composition comprising 800 to 1200 IU of Vitamin D and further comprising the oleuropein to an individual in need of same, wherein the composition is administered to the individual at least once per day, for a time period of at least 2 months.

2. The method according to claim 1 , wherein the composition comprises 850 to 1000 IU of the Vitamin D.

3. The method according to claim 1 , wherein the composition comprises 900 to 950 IU of the Vitamin D.

4. The method according to claim 1 , wherein the composition comprises from 0.01 mg to 1 g of the oleuropein.

5. The method according to claim 1 , wherein the composition comprises one or more further bioactive molecules.

6. The method according to claim 5 , wherein the one or more further bioactive molecules comprise a mineral comprising calcium and/or magnesium.

7. The method according to claim 1 , wherein the individual is a member of an ageing population.

8. The method according to claim 1 , wherein the individual has a disorder linked to an imbalance in the relationship between bone formation and/or cartilage anabolism and bone resorption, and the composition comprises the oleuropein in an amount effective to potentiate stimulation of cartilage anabolism in the individual.

9. The method according to claim 1 , wherein the composition comprises the oleuropein in an amount effective to maintain and/or improve mobility in the individual.

10. The method according to claim 8 , wherein the disorder is osteoporosis.

11. The method according to claim 1 , wherein the composition is a nutritional composition.

12. A method of treatment and/or alleviation of a disorder linked to an imbalance in bone and/or cartilage metabolism, the method comprising administering a composition comprising an effective amount of 800 to 1200 IU of Vitamin D in combination with oleuropein to an individual having the disorder, wherein the composition is administered at least once per day, for a time period of at least 2 months.

13. The method according to claim 12 , wherein the composition comprises one or more further bioactive molecules.

14. The method according to claim 13 , wherein the one or more further bioactive molecules comprise a mineral comprising calcium and/or magnesium.

15. The method according to claim 12 , wherein the composition comprises 0.01 mg to 1 g of the oleuropein.

16. The method according to claim 12 , wherein the composition comprises the oleuropein in an amount effective to potentiate stimulation of bone formation and/or cartilage anabolism in the individual.

17. The method according to claim 12 , wherein the composition comprises the oleuropein in an amount effective to maintain and/or improve mobility in the individual.

18. The method according to claim 12 , wherein the disorder is osteoporosis.

19. The method according to claim 12 , wherein the composition is a nutritional composition.

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0001 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0165 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ENGLISH TRANSLATION TO SHOW THE FULL AND CORRECT NEW NAME IN SECTION 51. PREVIOUSLY RECORDED AT REEL: 049391 FRAME: 0756. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER. Recorded Jun 13, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049853/0398 →
MERGER Recorded Jun 6, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049391/0756 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 17, 2016
From: HORCAJADA, MARIE NOELLE; MEMBREZ, FANNY; OFFORD CAVIN, ELIZABETH
To: NESTEC S.A.
Reel/Frame 040354/0910 →